FibroBiologics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 128.2% | 128.2% | -106.2% |
| FY2023 | -1,315.6% | -1,315.6% | -139.5% |
| FY2024 | -408.1% | -408.1% | -67.9% |
| FY2025 | -302.9% | -302.9% | -193.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 128.2% | 128.2% | -106.2% |
| FY2023 | -1,315.6% | -1,315.6% | -139.5% |
| FY2024 | -408.1% | -408.1% | -67.9% |
| FY2025 | -302.9% | -302.9% | -193.8% |